Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abacus Health Products Inc stock logo
ABAHF
Abacus Health Products
$4.84
-5.1%
$4.84
$1.12
$8.40
N/AN/A10,164 shs9,300 shs
Acreage Holdings, Inc. stock logo
ACRGF
Acreage
$2.77
$2.77
$1.47
$9.11
N/AN/A340,301 shsN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$279.41
-2.1%
$328.31
$261.59
$473.50
$7.97B0.87202,275 shs96,440 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abacus Health Products Inc stock logo
ABAHF
Abacus Health Products
0.00%0.00%0.00%0.00%0.00%
Acreage Holdings, Inc. stock logo
ACRGF
Acreage
0.00%0.00%0.00%0.00%0.00%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
+2.04%-2.47%-18.50%-9.77%-38.15%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abacus Health Products Inc stock logo
ABAHF
Abacus Health Products
N/AN/AN/AN/AN/AN/AN/AN/A
Acreage Holdings, Inc. stock logo
ACRGF
Acreage
N/AN/AN/AN/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.6995 of 5 stars
3.44.00.04.21.83.31.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abacus Health Products Inc stock logo
ABAHF
Abacus Health Products
N/AN/AN/AN/A
Acreage Holdings, Inc. stock logo
ACRGF
Acreage
N/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.80
Moderate Buy$468.0067.50% Upside

Current Analyst Ratings

Latest BIO, ABAHF, ACRGF, and AGH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/3/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$400.00 ➝ $365.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$395.00 ➝ $420.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$484.00 ➝ $480.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abacus Health Products Inc stock logo
ABAHF
Abacus Health Products
N/AN/AN/AN/AN/AN/A
Acreage Holdings, Inc. stock logo
ACRGF
Acreage
N/AN/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.67B2.98$12.07 per share23.14$306.51 per share0.91

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abacus Health Products Inc stock logo
ABAHF
Abacus Health Products
N/AN/A0.00N/AN/AN/AN/AN/A
Acreage Holdings, Inc. stock logo
ACRGF
Acreage
N/AN/A0.00N/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$637.32M-$21.49N/A24.38N/A-23.86%3.90%2.77%5/7/2024 (Confirmed)

Latest BIO, ABAHF, ACRGF, and AGH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.04N/A-$2.04N/AN/AN/A  
2/15/2024Q4 2023
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.93$3.10+$0.17-$5.94$685.00 million$681.18 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abacus Health Products Inc stock logo
ABAHF
Abacus Health Products
N/AN/AN/AN/AN/A
Acreage Holdings, Inc. stock logo
ACRGF
Acreage
N/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abacus Health Products Inc stock logo
ABAHF
Abacus Health Products
N/AN/AN/A
Acreage Holdings, Inc. stock logo
ACRGF
Acreage
N/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.14
5.83
4.34

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abacus Health Products Inc stock logo
ABAHF
Abacus Health Products
N/A
Acreage Holdings, Inc. stock logo
ACRGF
Acreage
N/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%

Insider Ownership

CompanyInsider Ownership
Abacus Health Products Inc stock logo
ABAHF
Abacus Health Products
N/A
Acreage Holdings, Inc. stock logo
ACRGF
Acreage
N/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
17.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abacus Health Products Inc stock logo
ABAHF
Abacus Health Products
29N/AN/ANot Optionable
Acreage Holdings, Inc. stock logo
ACRGF
Acreage
N/AN/AN/ANot Optionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
8,03028.52 million23.53 millionOptionable

BIO, ABAHF, ACRGF, and AGH Headlines

SourceHeadline
S&P 500 (SPX) today: Top movers are Bio-Rad Laboratories Inc and Agilent Technologies, Inc.S&P 500 (SPX) today: Top movers are Bio-Rad Laboratories Inc and Agilent Technologies, Inc.
usatoday.com - April 23 at 3:09 PM
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Duality Advisers LPBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Duality Advisers LP
marketbeat.com - April 22 at 11:54 AM
Kornitzer Capital Management Inc. KS Cuts Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Kornitzer Capital Management Inc. KS Cuts Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
marketbeat.com - April 20 at 11:18 AM
Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down to $290.86Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down to $290.86
americanbankingnews.com - April 20 at 6:26 AM
Commit To Purchase Bio-Rad Laboratories At $185, Earn 1.3% Annualized Using OptionsCommit To Purchase Bio-Rad Laboratories At $185, Earn 1.3% Annualized Using Options
nasdaq.com - April 19 at 11:28 PM
New Strong Sell Stocks for April 19thNew Strong Sell Stocks for April 19th
zacks.com - April 19 at 5:26 AM
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
zacks.com - April 18 at 11:06 AM
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
businesswire.com - April 18 at 9:00 AM
Bio-Rad Laboratories, Inc. (NYSE:BIO) Forecasted to Post Q1 2025 Earnings of $2.39 Per ShareBio-Rad Laboratories, Inc. (NYSE:BIO) Forecasted to Post Q1 2025 Earnings of $2.39 Per Share
americanbankingnews.com - April 18 at 2:56 AM
Bio-Rad Laboratories, Inc. (NYSE:BIO) to Post Q1 2025 Earnings of $2.39 Per Share, Zacks Research ForecastsBio-Rad Laboratories, Inc. (NYSE:BIO) to Post Q1 2025 Earnings of $2.39 Per Share, Zacks Research Forecasts
marketbeat.com - April 17 at 5:55 PM
Zacks Research Weighs in on Bio-Rad Laboratories, Inc.s Q1 2024 Earnings (NYSE:BIO)Zacks Research Weighs in on Bio-Rad Laboratories, Inc.'s Q1 2024 Earnings (NYSE:BIO)
americanbankingnews.com - April 17 at 1:22 AM
Bio-Rad (BIO) Hurt by Softness in BioPharma and CompetitionBio-Rad (BIO) Hurt by Softness in BioPharma and Competition
zacks.com - April 16 at 12:01 PM
Zacks Research Equities Analysts Reduce Earnings Estimates for Bio-Rad Laboratories, Inc. (NYSE:BIO)Zacks Research Equities Analysts Reduce Earnings Estimates for Bio-Rad Laboratories, Inc. (NYSE:BIO)
marketbeat.com - April 16 at 7:27 AM
Lecap Asset Management Ltd. Purchases New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Lecap Asset Management Ltd. Purchases New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)
marketbeat.com - April 13 at 8:08 PM
Cell Lysis Cell Fractionation Market Size, Share, Growth Statistics, Latest Trends, and Forecast to 2024 to 2032Cell Lysis Cell Fractionation Market Size, Share, Growth Statistics, Latest Trends, and Forecast to 2024 to 2032
taiwannews.com.tw - April 13 at 8:01 AM
Unlock the Potential of Hydroxyapatite: 7.8% CAGR Market Opportunity in Medical ImplantsUnlock the Potential of Hydroxyapatite: 7.8% CAGR Market Opportunity in Medical Implants
fmiblog.com - April 13 at 8:01 AM
Raymond James & Associates Sells 21,649 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Raymond James & Associates Sells 21,649 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)
marketbeat.com - April 12 at 4:18 AM
Bio-Rad and Alleghany Health Network partner for patients with solid tumour cancerBio-Rad and Alleghany Health Network partner for patients with solid tumour cancer
pharmatimes.com - April 11 at 11:29 PM
Bio-Rad and Allegheny Health Network Cancer Institute Collaborate to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCRBio-Rad and Allegheny Health Network Cancer Institute Collaborate to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCR
the-scientist.com - April 11 at 11:29 PM
Oncocyte, Bio-Rad Partner on Global Launch of Transplant AssayOncocyte, Bio-Rad Partner on Global Launch of Transplant Assay
marketwatch.com - April 11 at 6:28 PM
Oncocyte stock rallies 90% post-market on Bio-Rad partnershipOncocyte stock rallies 90% post-market on Bio-Rad partnership
seekingalpha.com - April 11 at 6:28 PM
Oncocyte and Bio-Rad Partner on Global Launch of Transplant AssayOncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
prismmediawire.com - April 11 at 5:44 PM
Bio-Rad Laboratories (NYSE:BIO) Stock Price Down 3.9%Bio-Rad Laboratories (NYSE:BIO) Stock Price Down 3.9%
marketbeat.com - April 11 at 1:48 PM
Allspring Global Investments Holdings LLC Has $53.64 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Allspring Global Investments Holdings LLC Has $53.64 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
marketbeat.com - April 11 at 6:58 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abacus Health Products logo

Abacus Health Products

OTCMKTS:ABAHF
Abacus Health Products, Inc. manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemps. The company offers CBD CLINIC line of products for relief from acute musculoskeletal and joint pain, which includes analgesic ointments, creams, and pain sticks, as well as analgesic massage oils. It also provides CBDMEDIC line of products, such as sport ointments and pain sticks, back and neck ointments, arthritis hand creams and ointments, and massage therapy oils, as well as ointments and pain sprays for muscles and joints. The company offers its CBD CLINIC products to registered health practitioners, including chiropractors, acupuncturists, massage and physical therapists, naturopaths, and osteopaths; and CBDMEDIC products directly to consumers through retail pharmacy chains and fitness locations, as well as online through the e-commerce platform. In addition, it is involved in developing a pipeline of other OTC CBD products addressing additional medical indications and the health and wellness sectors. The company is headquartered in Toronto, Canada. Abacus Health Products, Inc. is a subsidiary of Aidance Skincare & Topical Solutions, LLC.
Acreage logo

Acreage

OTCMKTS:ACRGF
Acreage Holdings, Inc. engages in owning and operating cannabis licenses and assets in the U.S. with respect to the number of states with cannabis related licenses. It focuses on the cultivation, processing, and distribution operations. The company was founded by Kevin P. Murphy on July 12, 1989 and is headquartered in New York, NY.
Bio-Rad Laboratories logo

Bio-Rad Laboratories

NYSE:BIO
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.